Creo Medical Group Plc · LSE:CREO
Creo Medical — Investor Presentation (October 2018)
20 slides from Creo Medical's investor presentation, Oct 17, 2018
Slide 1: Bringing Advanced Energy to Endoscopy - Investor Open Event
CREO MEDICAL BRINGING ADVANCED ENERGY TO ENDOSCOPY Investor Open Event 17 October 2018
Slide 2: Disclaimer
2 DISCLAIMER IMPORTANT NOTICE This presentation comprises the written materials/slides for a presentation concerning Creo Medical Group PLC (the “Company”) and its Investor Open Event at Chepstow. By reviewing this presentation you agree to be bound by the conditions set out below. No reliance may b
Slide 3: Agenda
3 Agenda 14:30 – 14:45 – Registration 14:45 – 15:30 – Welcome, Introduction to senior management by Craig Gulliford & Investor Presentation (45 mins) 15:30 – 15:45 – Q&A (15 mins) 15:45 – 16:00 – Group A tour of facility / Group B product demonstration / conversations with senior team member
Slide 4: Overview
4 OVERVIEW Focused on the Emerging Field of Surgical Endoscopy to perform clinical procedures minimally and non-invasively Creo Medical utilises patented technology combining microwave and bi-polar radio frequency energy via its advanced energy platform Enabling a wide range of miniature endoscopic
Slide 5: Facts and Figures
5 FACTS AND FIGURES ~50 People Employed in a Creative, Innovative, Fun and Driven Environment with the aim to change lives! Listed on London Stock Exchange in December 2016 raising £20M to further develop IP, with a further raise of £48.5M in August 2018 to fully commercialise our products so that w
Slide 6: Our Board
6 OUR BOARD Charles Spicer, Chairman David G. Woods, NED Specialist medtech director, President, CEO of Pentax Americas Aircraft Medical, Stanmore Implants, Proven track record in General and Orthopedic Medivance, Vision RT, 11 Health, PuriCore, Surgery, Gastroenterology, Pulmonology and ENT
Slide 7: The Rapid Rise of Endoscopy
7 THE RAPID RISE OF ENDOSCOPY “A leap in the advancement of colonic submucosal dissection…” Dr. Zacharias P. Tsiamoulos MBBS, PHD PARADIGM SHIFT Endoscopy Clinical Lead, Consultant in Gastroenterology and Advances in single-port laparoscopy, Specialist in GI Endoscopy East Kent University Hospitals
Slide 8: Advanced Energy Platform
8 ADVANCED ENERGY PLATFORM 15 years ago microwave was used in Telecoms but was not sufficiently advanced & too expensive for use in endoscopy Microwave for controlled coagulation & Bi-polar RF for precise cutting Laparoscopic surgeons have Bi-polar RF and harmonic devices, however will not use mono-
Slide 9: GI Devices
9 GI DEVICES Growth of GI indications Suite of GI Devices: • Poor diet, obesity, sedentary lifestyles and an aging population is driving growth in the Endoscopy device market. • Continued expansion in endoscopic screening programs driving an increase in the detection rates for a range of conditions
Slide 10: Speedboat RS2
10 SPEEDBOAT RS2 “You don’t have to be an expert to use Speedboat” Dr Francisco Jose García Fernández, Spain COLORECTAL CANCER 1 INTEGRATED INJECTION NEEDLE no instrument exchange required WORLDWIDE: 16m screening colonoscopies are performed per annum in the US1 5 ROTATION orientation in any plane 1
Slide 11: Example Clinical Cases Performed Using Speedboat
11 EXAMPLE CLINICAL CASES PERFORMED USING SPEEDBOAT 90 mm lesion 25 mm lesion 20 mm lesion 89 year old 64 year old male 63 year old male female Removed Removed under Removed under conscious sedation without sedation general in under 40 in under 30 anesthesia in minutes minutes unde
Slide 12: The Alternative
12 THE ALTERNATIVE Up to 30cm of bowel removed and the two sections re-joined Change to the anatomy of the patient – never the same again in terms of function Colostomy bag for at least 6 months or life Other associated effects such as depression One of these patients could not have tolera
Slide 13: Physicians Trained
13 PHYSICIANS TRAINED Goal: 50> by end of 2018 PHYSICIANS TRAINED: 45* ACCUMULATED UK Europe US AsiaPac Africa Endoscopist Nurse in training Colorectal Surgeon Nurse not trained Nurse trained later “I can’t thank you enough for a fantastic experience. As you know I’m sure there is a tremendous futur
Slide 14: Ablation Devices
14 ABLATION DEVICES LUNG CANCER: PANCREATIC CANCER: Screening not performed In 2018 ~55,440 Americans will be diagnosed with pancreatic cancer in the 1.8m Global cases of lung cancer each U.S., and over 44,330 will die.4 Surgery year1 One of the few cancers for which survival 15% has not improved su
Slide 15: Paradigm Shift
15 PARADIGM SHIFT “The Speedboat is a very nifty and elegant device and I am sure it will do well, and I hope it finds even more uses than just colorectal. I also very much look forward to your future products which all look so promising” Dr Galya Chinnery, South Africa Clinical Education Program Ke
Slide 16: Growth of Distributors 2018 & 2019
16 GROWTH OF DISTRIBUTORS 2018 & 2019 Framework distribution agreements Pentax Europe Draft framework agreements for distributors: Pentax APAC APAC – Pentax – existing agreement, commencement of distribution underway Direct / Distribution TBD Central and Eastern Europe – Initial discussions with
Slide 17: ISO:13485 Audited R&D and Manufacturing Capability
17 ISO:13485 AUDITED R&D AND MANUFACTURING CAPABILITY We have dedicated spaces for: Innovation (Bath) Design & development (Bath/Chepstow) Cleanroom manufacturing & assembly (Chepstow) Capacity for growth: Upstream & downstream manufacturing currently at scale Growth requires a need to
Slide 18: Key Milestones
18 KEY MILESTONES 2017 2018 2019 Generator & instruments with EU KOL’s FDA clearance of the Speedboat RS2 Develop a distributor network for regions outside the core markets CE Mark for the Generator & Speedboat RS2 KOL advocacy phase for Speedboat RS2 in US market Continued roll-out of ins
Slide 19: Conclusion
19 CONCLUSION Creo’s advanced energy platform – utilises Creo’s patented technology to combine microwave and bi-polar radio frequency energy and enables a wide range of miniature endoscopic devices with precise cut, coagulation and ablation capability saving time and cost 2018 Fundraise has stre
Slide 20: Anything Is Possible with the Right Approach
20 CREO MEDICAL ANYTHING IS POSSIBLE WITH THE RIGHT APPROACH
Creo Medical Group — Investor Presentation (October 2018) on 6ix